Thursday 26 September 2013

07:45 - 09:00

Oral Posters (main auditorium)

Chairs: Eugeny Rybakov (Russia), Ioannis Karaitianos (Greece)

• OP13: The lymph node ratio may increase the prognostic value of TNM classification in patients affected by colorectal cancer - Renato Costi (Dipartimento di Scienze Chirurgiche, Università di Parma, Italy)
• OP14: 16S rRNA gene analysis (metataxonomics) of the ascending colonic cancer microbiological ecosystem - James Kinross (Imperial College London, UK)
• OP15: Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer - Josefin Segelman (Karolinska Institutet, Sweden and Ersta Hospital, Sweden)
• OP16: Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer - Min Jung Kim (Seoul National University College of Medicine, Republic of Korea)
• OP17: Robotic assisted total mesorectal resection has good short term and long term outcomes - Wah Siew Tan (Department of Colorectal Surgery, Singapore General Hospital, Singapore)
• OP18: Concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer: 3-year follow-up of a phase II study - Sergey Gordeyev (Russian N.N.Blokhin Cancer Research Center, Russia)
• OP19: One in three patients require a stoma in cytoreductive surgery for peritoneal malignancy and in half the stoma is permanent: experience with 958 patients - Stefan Riss (Basingstoke and North Hampshire Hospital, UK)
• OP20: Self-expanding metal stents for palliative treatment of malignant obstructions in patients with advanced colorectal cancer - Tore Tholfsen (Stavanger University Hospital, Norway)
• OP21: Quality of life of rectal cancer survivors is severely affected by bowel dysfunction - results from an international multicenter study - Therese Juul (Department of Surgery P, Aarhus University Hospital, Denmark)
• OP22: Polyp cancers: analysis of pathological features predictive of node metastases - Leonardo Centonze (Whipps Cross University Hospital, UK and Sapienza University in Rome, Italy)
• OP23: How useful is magnetic resonance imaging in detecting anal cancer recurrence? - Jan Lee (The Northern General Hospital, UK)
• OP24: A preoperative neutrophil to lymphocyte ratio of three predicts disease-free survival after curative elective colorectal cancer surgery - George Malietzis (Department of Colorectal Surgery, St Mark's Hospital, UK)
• OP25: The effects of colorectal cancer surgery on patient’s quality of life: the spouse’s perspective - Gokce Aylaz (Ankara University, Turkey)
• OP26: The impact of wound-edge protection devices on surgical site infection after laparotomy (ROSSINI Trial): a multicentre randomised controlled trial
  Thomas Pinkney (West Midlands Research Collaborative, UK and Academic Department of Surgery, University of Birmingham, UK)
• OP27: Colorectal tissue engineering: comparative in vivo and in vitro study for optimal scaffold selection - Quentin Denost (CHU Bordeaux, Saint André Hospital, Department of Digestive Surgery, France and INSERM, Bioingenierie tissulaire, U1026, France)

Oral Posters (parallel auditorium)

Chairs: Gervasio Selgado (Spain), B. Bulent Mentes (Turkey)

• OP28: Standard anorectal investigations for management of faecal incontinence: how much do they really tell us? - Michael Feretis (Heart of England NHS Foundation Trust, UK)
• OP29: Robot-assisted versus laparoscopic ventral rectopexy in the treatment of rectal prolapse or intussusception: a randomized controlled trial - Johanna Mäkelä-Kaikkonen (University hospital of Oulu, Finland)
• OP30: Rectal hyposensitivity: clinical presentation, physiological findings and potential causative factors. A 5-year single centre experience - Michael Feretis (Heart of England NHS Foundation Trust, UK)
• OP31: Pudendal nerve stimulation in the treatment of faecal incontinence - Gregory Thomas (St Mark's Hospital and Academic Institute, UK)
• OP32: Posterior tibial nerve stimulation versus sacral nerve stimulation for faecal incontinence: a comparative case-matched study - Sami Al Asari (University Hospital, France)
• OP33: Accuracy of the preoperative endoanal sonography in fistula in-ano - Leila Ghahramani (Colorectal Research Center, Shiraz university of Medical Sciences, Iran)
• OP34: Electrophysiological neuromonitoring in colorectal surgery indicates the potential superiority of nerve-sparing with the laparoscopic approach - Daniel W Kauff (University Medicine of the Johannes Gutenberg-University, Germany)
• OP35: Predictive factors for the outcome of transanal advancement flap repair - Robbert Sebastiaan van Onkelen (Erasmus MC, University Medical Center, The Netherlands)
• OP36: The immunopathogenesis of perianal fistulae - dendritic cell expression of toll-like receptors 2 and 4 - Nuha Yassin (St Mark's Hospital, UK)
• OP37: Treatment of transsphincteric anorectal fistulas in France using a biologic plug - Emmanuel ODET (Centre hospitalier de Mâcon, France)
• OP38: Video assisted anal fistula treatment: a new concept of treating anal fistulas - Piercarlo Meinero (Department of General Surgery, Proctological Unit - Azienda Sanitaria Locale No. 4 Chiavarese, Italy)
• OP40: Preliminary results of cryptoglandular anal fistula treatment by autologous platelet rich fibrin (PRF) - Sylvain Kirzin (CHU de Toulouse, France)
• OP41: Characteristics of high and low transsphincteric fistulas
  Robbert Sebastiaan van Onkelen (Erasmus MC, University Medical Center, The Netherlands)
• OP42: An interesting first line treatment in anal fissures: the injection of a sclerosing agent - Michael Dessily (Centre Hospitalier Universitaire de Tivoli, Belgium)

New: Educational Workshop: Spotlight Endoscopic Coloproctology.

Workshop arranged by Karl Storz.

09:00 - 10:00

Research Focus: Standardising Outcomes (main auditorium)

Chairs: Dion Morton (UK) - main chair, Carolynne Vaizey (UK) - report chair

• Lecture: Standardising outcomes in surgical trials - Jane Blazeby (UK)
• Report: Standardising outcomes in FBD studies - Julie Cornish (UK), Katherine Gill (UK) on behalf of the Standardising Outcomes Sub-Committee
• Panel discussion - Jane Blazeby (UK), Julie Cornish (UK), André D'Hoore (Belgium), Katherine Gill (UK), Tom Oresland (Norway)

Keynote Lecture: Haemorrhoids: cut, pexy, ligation: when and how (main auditorium)

Chair: Zoran Krivokapic (Serbia)

Speaker: Thomas Schiedeck (Germany)

Supported by Colorectal Disease

10:45 - 11:30

New: Industry 'Focus' Workshop: How to lower the risk of surgery (main auditorium)

This year's topic: Anastomotic risk.

Chairs: Paul-Antoine Lehur (France), Michel Adamina (Switerland), Mike Parker (UK)

11:30 - 12:30

Symposium: Recto-urogenital fistulas (main auditorium)

Chairs: Algimantas Tamelis (Lithuania), Mike Parker (UK)

• Benign rectovaginal fistulas - Alois Fürst (Germany)
• Post radiation and malignant rectovaginal fistulas - Yury Shelygin (Russia)
• Rectourethral fistulas - André D'Hoore (Belgium)

Keynote Lecture: Genetics of IBD (main auditorium)

Chair: Emmanuel Tiret (France)

Speaker: Jean-Pierre Hugot (France)

13:00 - 14:30

Trainee Lunch Workshop (Hall 1)

14:30 - 16:00

The Six Best and Visiting Fellow Free Papers  (main auditorium)

Chairs: Søren Laurberg (Denmark), Peter Dawson (UK)

ASCRS Visiting Fellow Free Paper:

• Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? - Angelita Habr-Gama (Angelita Joapuim Gama Institute, Sao Paulo, Brazil)

Japanese Visiting Fellow Free Paper:

• The impact of lymph nodal positivity and its contributing pathologic factors on recurrence after curative surgery for submucosal invasive colorectal cancer - Shingo Tsujinaka (Department of Surgery, Jichi Medical University, Saitama Medical Center, Saitama, Japan)

The Six Best ESCP Free Papers:

• B1: Evaluation of anorectal function after low anterior resection for adenocarcinoma of the rectum - a 5-year follow-up of a randomized multicenter trial - Hannah Floodeen (Örebro University Hospital, Sweden)
• B2: An MRI staging system for low rectal cancer aids stratification of tumours which are high and low risk for distal mesorectal margin involvement: experience from the MERCURY II Study - Nick Battersby (Pelican Cancer Foundation, UK)
• B3: Long-term outcome of SNS in the treatment for fecal incontinence. A European survey - Simona Giuratrabocchetta (Dept of Emergency and Organ Transplantation, University Aldo Moro of Bari, Italy)
• B4: Randomized controlled trial comparing seton removal alone or in association with anal fistula plug in fistulising ano-perineal Crohn’s disease - Agnes Senejoux (CHU Beaujon, France)
• B5: Local excision versus radical resection of colorectal carcinoma - Aneel Bhangu (Imperial College London, UK and Royal Marsden Hospital, UK)
• B6: Bowel dysfunction after rectal cancer treatment - a study comparing the specialist’s versus patient’s perspective - Tina Yen-Ting Chen (Aarhus University Hospital, Denmark)

16:15 - 17:15

Symposium: Faecal incontinence: Toward a less invasive approach (main auditorium)

Chairs: Carlo Ratto (Italy), Paul Antoine Lehur (France)

• Sphincteroplasty today - Goran Barisic (Serbia)
• Injectable prosthesis and bulking agents - Lilli Lundby (Denmark)
• Sacral nerve stimulation and posterior tibilal nerve stimulation - Carolynne Vaizey (UK)

17:15 - 18:15

Free Papers (main auditorium)

Chairs: Dragomir Dardanov (Bulgaria), Peter-Paul Coene (Netherlands)

• F01: Almost 20% of defunctioning stomas are never reversed after colo-anal anastomosis for low rectal cancer: experience from the MERCURY II Low Rectal Cancer Study - Nick Battersby (Pelican Cancer Foundation, UK)
• F02: Does complete mesocolic excision (CME) improve survival among patients with right sided colon cancer? - Richard Bernhoff (Dept of Molecular medicine and Surgery, Karolinska Institutet, Sweden)
• F03: Consensus statement on the management of patients with primary rectal cancer beyond total mesorectal excision planes and recurrent rectal cancer - Aneel Bhangu (Royal Marsden Hospital, UK)
• F04: The impact of enhanced recovery protocol compliance on outcome following elective colorectal cancer resection - Andrew Currie (St Mark's Hospital and Academic Institute, UK)
• F05: The impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. A prospective multicentre study - Katrine J. Emmertsen (Aarhus University Hospital, Denmark)
• F06: Synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study - Andreas Nordholm-Carstensen (Department of Surgery, University Hospital of Copenhagen, Bispebjerg Hospital, Denmark)

Free Papers (parallel auditorium)

Chairs: Michael Machado (Sweden), Goran Stanojevic (Serbia)

• F07: Swedish patients operated with Extralevator APE (ELAPE) - Mattias Prytz (Department of Surgery NU-Hospital Organisation, Sweden and SSORG, University of Gothenburg, Sweden)
• F08: The 'Fast-Track' referral system for patients with suspected coloretal cancer: has it affected outcomes? - Harriet Reader (Hull/York Medical School, UK)
• F09: Tailoring the surgical strategy of distal rectal cancer with synchronous liver metastases remains difficult. An intention to treat analysis - Charles Sabbagh (University hospital of Amiens, France)
• F10: Regression of extramural venous invasion after neoadjuvant chemoradiotherapy improves disease-free survival in rectal cancer - Manish Chand (Royal Marsden Hospital, UK and Imperial College, UK)
• F11: Results of partial mesorectal resection: a series of 172 upper third rectal cancers - Jeremie Lefevre (Hopital Saint-Antoine, France)
• F12: Sphincter saving resections for rectal cancer in the UK and USA - a population based study - Catherine Bryant (Queen Mary University of London, UK)

18:15 - 19:00

Annual General Meeting  (main auditorium)

20:00